Skip to main content
main-content

Neuer Inhalt Free registration

Gain full access to the latest clinical content available from Springer Nature

Editors' pick

09-02-2018 | Rheumatoid arthritis | Feature | News

Should treatment be tapered in patients with RA?

medwireNews speaks to Vivian Bykerk about whether treatment should be tapered in patients with rheumatoid arthritis.

20-02-2018 | Osteoarthritis | News

Trial results do not support hydroxychloroquine for hand OA

Results of the HERO trial suggest that the addition of hydroxychloroquine to standard care does not further reduce pain among patients with hand osteoarthritis .

14-02-2018 | Rheumatology nursing | Editorial | Article

The role of the clinical nurse specialist/advanced nurse practitioner in rheumatology practice: Past, present and future

Advanced nurse practitioner Patricia Minnock discusses the development of the roles of advanced nurse practitioner and clinical nurse specialist within the field of rheumatology.

Latest from across the site

22-02-2018 | Systemic lupus erythematosus | News

Long-term results confirm sustained benefits of belimumab in SLE patients

Results of the BLISS-76 continuation study suggest that long-term treatment with belimumab alongside standard care is associated with sustained efficacy and a stable adverse event profile among patients with systemic lupus erythematosus.

Source:

Arthritis Rheumatol 2018; Advance online publication

21-02-2018 | Rheumatoid arthritis | News

News in brief

Methotrexate associated with reduced dementia risk in RA patients

The use of conventional DMARDs, especially methotrexate, is associated with a reduced risk for dementia among patients with rheumatoid arthritis, researchers report.

21-02-2018 | Gout | Editorial | Article

Gout therapies and cardiovascular risk

Editorial Board member Fernando Pérez-Ruiz highlights recent clinical trials evaluating the effect of febuxostat on risk of cardiovascular comorbidities, and discusses alternative treatments for gout patients with cardiovascular disease.

Author:
Fernando Pérez-Ruiz

20-02-2018 | Osteoarthritis | News

Trial results do not support hydroxychloroquine for hand OA

Results of the HERO trial suggest that the addition of hydroxychloroquine to standard care does not further reduce pain among patients with hand osteoarthritis .

Source:

Ann Intern Med 2018; Advance online publication

19-02-2018 | Psoriatic arthritis | News

Secukinumab boosts chances of minimal disease activity for PsA patients

Patients with psoriatic arthritis who are treated with the interkeukin-17 inhibitor secukinumab have an increased likelihood of achieving minimal disease activity, suggests an analysis of data from the FUTURE 2 trial.

Source:

Arthritis Care Res 2018; Advance online publication

16-02-2018 | Rheumatoid arthritis | News

Head-to-head trials of IL-6 inhibitors warranted in RA patients

Different biologic agents targeting the interleukin-6 signaling pathway may have distinct efficacy profiles in patients with rheumatoid arthritis, South Korean researchers report.

Source:

Clin Rheumatol 2018; Advance online publication

Meet our Editorial Board

New Content Item Meet our Advisory Board

image credits